Page last updated: 2024-10-22

amsacrine and Factor X Deficiency

amsacrine has been researched along with Factor X Deficiency in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Factor X Deficiency: Blood coagulation disorder usually inherited as an autosomal recessive trait, though it can be acquired. It is characterized by defective activity in both the intrinsic and extrinsic pathways, impaired thromboplastin time, and impaired prothrombin consumption.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carter, C1
Winfield, DA1

Other Studies

1 other study available for amsacrine and Factor X Deficiency

ArticleYear
Factor X deficiency during treatment of relapsed acute myeloid leukaemia with amsacrine.
    Clinical and laboratory haematology, 1988, Volume: 10, Issue:2

    Topics: Adult; Amsacrine; Blood Transfusion; Drug Therapy, Combination; Etoposide; Factor IX; Factor X; Fact

1988